Immunological parameters as biomarkers of response to MicroCrystalline Tyrosine-adjuvanted mite immunotherapy

Immunological parameters as biomarkers of response to MicroCrystalline Tyrosine-adjuvanted mite immunotherapy

Background: Despite the effectiveness of allergen immunotherapy (AIT), some patients are unresponsive for reasons still unknown; yet validated response biomarkers remain unavailable. Objective: To analyze immunological parameters as biomarkers to monitor and predict clinical response to a MicroCryst...

Full description

Bibliographic Details
Main Authors:	José L. Justicia, Clara Padró, Albert Roger, Francisco Moreno, Manuel J. Rial, Antonio Parra, Antonio Valero, Alfons Malet, Aina Teniente, Anna Boronat, Carla Torán-Barona
Format:	Article
Language:	English
Published:	Elsevier 2021-06-01
Series:	World Allergy Organization Journal
Subjects:	House dust mite Allergic rhinitis Subcutaneous allergen immunotherapy Microcrystalline Tyrosine Immunological biomarkers Sensitization profile
Online Access:	http://www.sciencedirect.com/science/article/pii/S1939455121000399

Similar Items

Effectiveness and safety of a microcrystalline tyrosine‐adjuvanted Dermatophagoides pteronyssinus allergoid immunotherapy in adult patients with allergic asthma and rhinitis: A real‐life prospective observational study
by: Clara Padró, et al.
Published: (2022-05-01)

Effectiveness and safety of a glutaraldehyde-modified, L-tyrosine-adsorbed and monophosphoryl lipid A-Adjuvanted allergen immunotherapy in patients with allergic asthma sensitized to olive pollen: A retrospective, controlled real-world study
by: José Fernando Florido-López, et al.
Published: (2020-12-01)

Comparison of rush-subcutaneous and sublingual immunotherapy with house dust mite extract for pediatric allergic rhinitis: A prospective cohort study
by: Masaaki Hamada, et al.
Published: (2023-10-01)

Consideration of methods for identifying mite allergens
by: Yubao Cui, et al.
Published: (2018-04-01)

Sensitization to environmental mites and fungi in pediatric patients with asthma and allergic rhinitis
by: Lourdes Leonor Bermudez-Cordoví, et al.
Published: (2021-05-01)

Depiction of Major Mite Allergens in Severe Allergic Rhinitis with High Mite Perennial Exposure
by: Ruperto González-Pérez, et al.
Published: (2020-09-01)

Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
by: Yaqi Yang, et al.
Published: (2021-04-01)

Mites Are the Most Prevalent Allergen among Children with Severe Asthma in Gorgan, Iran
by: Mohsen Ebrahimi, et al.
Published: (2021-09-01)

Evaluation of the effectiveness of subcutaneous pollen weed polen allergens
by: L. Yu. Barycheva, et al.
Published: (2023-07-01)

Association between component-resolved diagnosis of house dust mite and efficacy of allergen immunotherapy in allergic rhinitis patients
by: Yanran Huang, et al.
Published: (2019-12-01)

Algorithm for selecting patients for house dust mite allergen specific im- munotherapy in children with bronchial asthma and allergic rhinitis
by: O. V. Trusova, et al.
Published: (2023-07-01)

360° approach to the patient with mite allergy: from scientific evidence to clinical practice
by: Antonio Nieto-García, et al.
Published: (2024-02-01)

Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®)
by: Matthew D. Heath, et al.
Published: (2020-11-01)

Clinical validation of controlled exposure to house dust mite in the environmental exposure unit (EEU)
by: Lubnaa Hossenbaccus, et al.
Published: (2021-03-01)

An Indian perspective on dust mites
by: S N Gaur
Published: (2019-01-01)

Characterization Of Allergens From Dust Mite (Tyrophagus Putrescentiae)
by: Sew, Yun Shin
Published: (2003)

Method and safety of nasal allergen provocational test with house dust mite allergen in children with bronchial asthma and allergic rhinitis
by: O. V. Trusova, et al.
Published: (2023-03-01)

Extraction and Characterization of Cellulose and Microcrystalline Cellulose from Teff Straw and Evaluation of the Microcrystalline Cellulose as Tablet Excipient
by: Melese Getachew, et al.
Published: (2023-11-01)

Intra-cervical lymphatic immunotherapy for dust mite-induced allergic rhinoconjunctivitis in children: a 3-year prospective randomized controlled trial
by: Qixing Wang, et al.
Published: (2023-08-01)

Role of Pollen Allergy in Taiwanese Patients With Allergic Rhinitis
by: Kai-Li Liang, et al.
Published: (2010-12-01)

House dust mites: invisible signs of visible problems. Modern approaches to the treatment of dust mite allergies
by: O.s. drobik, et al.
Published: (2013-12-01)

Poor sleep is highly associated with house dust mite allergic rhinitis in adults and children
by: Damien Leger, et al.
Published: (2017-08-01)

Effectiveness of Indonesian house dust mite allergenic extract in triggering allergic rhinitis sensitivity in a mouse model: A preliminary study
by: Yusuf Alif Pratama, et al.
Published: (2022-09-01)

Mite Sensitivity in Children with Allergy
by: E Mohammadzadeh,, et al.
Published: (2012-07-01)

House dust mite subcutaneous immunotherapy has sustained long‐term effectiveness on allergic rhinitis and asthma: A 10‐year follow‐up
by: Elena Rodriguez‐Plata, et al.
Published: (2023-10-01)

Subcutaneous Immunotherapy Improves the Symptomatology of Allergic Rhinitis
by: Edmir Américo Lourenço, et al.
Published: (2016-01-01)

A single center retrospective study of systemic reactions’ distribution and risk factors to subcutaneous immunotherapy with dust mite extract in patients with allergic rhinitis and/ or asthma
by: Xude Zhang, et al.
Published: (2023-01-01)

New approaches to immunotherapy in house dust mite allergy
by: In Sik Kim
Published: (2023-04-01)

New forms of home dust mite allergoid
by: V. M. Berzhets, et al.
Published: (2019-08-01)

Association of IgE profiles to micro-arrayed house dust mite allergens with allergic symptoms measured in a house dust mite challenge chamber
by: Azahara Rodríguez-Domínguez, et al.
Published: (2018-06-01)

Good clinical practice recommendations in allergen immunotherapy: Position paper of the Brazilian Association of Allergy and Immunology – ASBAI
by: Fernando Monteiro Aarestrup, MD, PhD, et al.
Published: (2022-10-01)

Storage Mite Precision Allergy Molecular Diagnosis in the Moderate-to-Severe T2-High Asthma Phenotype
by: Ruperto González-Pérez, et al.
Published: (2022-04-01)

Safety Profile and Issues of Subcutaneous Immunotherapy in the Treatment of Children with Allergic Rhinitis
by: Anang Endaryanto, et al.
Published: (2022-05-01)

Precision Medicine in Mite Allergic Rhinitis
by: Ruperto González-Pérez, et al.
Published: (2021-09-01)

En route to personalized medicine: uncovering distinct IgE reactivity pattern to house dust mite components in Brazilian and Austrian allergic patients
by: Carina S. Pinheiro, et al.
Published: (2021-03-01)

The Presence of House Dust Mites in Residences and Classrooms of Students with Allergic Rhinitis
by: Suri Dwi Lesmana, et al.
Published: (2021-07-01)

CHOICE international survey: Clusters of allergen immunotherapy prescription from French and Spanish cohorts
by: Pablo Rodriguez del Rio, MD, PhD, et al.
Published: (2023-06-01)

Immunotherapy and Asthma in Children
by: Maria A. Tosca, et al.
Published: (2018-08-01)

Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial
by: Corren J, et al.
Published: (2021-08-01)

Immunoinformatics and Similarity Analysis of House Dust Mite Tropomyosin
by: Mohammad Mehdi Ranjbar, et al.
Published: (2015-10-01)